Search Results - "Oyan, Başak"

Neoadjuvant Pembrolizumab Plus Chemotherapy in Early-Stage Triple-Negative Breast Cancer: A Nationwide Retrospective Turkish Oncology Group Study by Karci, Ebru, Bilici, Ahmet, Bayram, Buket, Celayir, Melisa, Ozyurt, Neslihan, Uluc, Başak Oyan, Eken, Aynur, Basaran, Gul, Demirci, Umut, Kemal, Yasemin, Oruncu, Mehmet Berk, Olmez, Omer Fatih, Selcukbiricik, Fatih, Korkmaz, Taner, Erturk, Ismail, Bilgetekin, Irem, Celik, Serkan, Turkel, Alper, Alkan, Ali, Sakin, Abdullah, Can, Orcun, Gunaldi, Meral, Esin, Ece, Yildiz, Ozcan

“…Following the results of the phase 3 KEYNOTE-522 trial, the U.S. Food and Drug Administration approved pembrolizumab, a humanized IgG4 kappa monoclonal…”
Get full text

Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer by Taşçı, Elif Şenocak, Oyan, Başak, Sönmez, Özlem, Mutlu, Arda Ulaş, Atcı, Muhammed Mustafa, Sakin, Abdullah, Öner, İrem, Çınkır, Havva Yeşil, Eryılmaz, Melek Karakurt, Çağlayan, Dilek, Balçık, Onur Yazdan, Paksoy, Nail, Karabulut, Senem, Salim, Derya Kıvrak, Bilir, Cemil, Özen, Miraç, Özçelik, Melike, Arıcan, Ali, Akagündüz, Baran, İnal, Ali, Aydın, Dinçer, Özer, Leyla, Gülmez, Ahmet, Turhal, Nazım Serdar, Esen, Selin Aktürk, Algın, Efnan, Akbaş, Sinem, İriağaç, Yakup, Şakalar, Teoman, Ünal, Çağlar, Er, Özlem, Seçmeler, Şaban, Bozkurt, Mustafa

“…The optimal treatment for metastatic colorectal cancer (mCRC) after the second line is still controversial. Regorafenib has been the standard of care in this…”
Get full text

Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy by Karacin, Cengiz, Oksuzoglu, Berna, Demirci, Ayşe, Keskinkılıç, Merve, Baytemür, Naziyet Köse, Yılmaz, Funda, Selvi, Oğuzhan, Erdem, Dilek, Avşar, Esin, Paksoy, Nail, Demir, Necla, Göksu, Sema Sezgin, Türker, Sema, Bayram, Ertuğrul, Çelebi, Abdüssamet, Yılmaz, Hatice, Kuzu, Ömer Faruk, Kahraman, Seda, Gökmen, İvo, Sakin, Abdullah, Alkan, Ali, Nayır, Erdinç, Uğraklı, Muzaffer, Acar, Ömer, Ertürk, İsmail, Demir, Hacer, Aslan, Ferit, Sönmez, Özlem, Korkmaz, Taner, Celayir, Özde Melisa, Karadağ, İbrahim, Kayıkçıoğlu, Erkan, Şakalar, Teoman, Öktem, İlker Nihat, Eren, Tülay, Urul, Enes, Mocan, Eda Eylemer, Kalkan, Ziya, Yıldırım, Nilgün, Ergün, Yakup, Akagündüz, Baran, Karakaya, Serdar, Kut, Engin, Teker, Fatih, Demirel, Burçin Çakan, Karaboyun, Kubilay, Almuradova, Elvina, Ünal, Olçun Ümit, Oyman, Abdilkerim, Işık, Deniz, Okutur, Kerem, Öztosun, Buğra, Gülbağcı, Burcu Belen, Kalender, Mehmet Emin, Şahin, Elif, Seyyar, Mustafa, Özdemir, Özlem, Selçukbiricik, Fatih, Kanıtez, Metin, Dede, İsa, Gümüş, Mahmut, Gökmen, Erhan, Yaren, Arzu, Menekşe, Serkan, Ebinç, Senar, Aksoy, Sercan, İmamoğlu, Gökşen İnanç, Altınbaş, Mustafa, Çetin, Bülent, Uluç, Başak Oyan, Er, Özlem, Karadurmuş, Nuri, Erdoğan, Atike Pınar, Artaç, Mehmet, Tanrıverdi, Özgür, Çiçin, İrfan, Şendur, Mehmet Ali Nahit, Oktay, Esin, Bayoğlu, İbrahim Vedat, Paydaş, Semra, Aydıner, Adnan, Salim, Derya Kıvrak, Geredeli, Çağlayan, Yavuzşen, Tuğba, Doğan, Mutlu, Hacıbekiroğlu, İlhan

“…There is no standard treatment recommended at category 1 level in international guidelines for subsequent therapy after cyclin-dependent kinase 4/6 inhibitor…”
Get full text

Correction: Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer by Taşçı, Elif Şenocak, Oyan, Başak, Sönmez, Özlem, Mutlu, Arda Ulaş, Atcı, Muhammed Mustafa, Sakin, Abdullah, Öner, İrem, Çınkır, Havva Yeşil, Eryılmaz, Melek Karakurt, Çağlayan, Dilek, Balçık, Onur Yazdan, Paksoy, Nail, Karabulut, Senem, Salim, Derya Kıvrak, Bilir, Cemil, Özen, Miraç, Özçelik, Melike, Arıcan, Ali, Akagündüz, Baran, İnal, Ali, Aydın, Dinçer, Özer, Leyla, Gülmez, Ahmet, Turhal, Nazım Serdar, Esen, Selin Aktürk, Algın, Efnan, Akbaş, Sinem, İriağaç, Yakup, Şakalar, Teoman, Ünal, Çağlar, Er, Özlem, Seçmeler, Şaban, Bozkurt, Mustafa

Get full text

Efficacy of adjuvant capecitabine in residual triple negative breast cancer: a multicenter observational Turkish Oncology Group (TOG) study by Taşçı, Elif Şenocak, Kutlu, Yasin, Ölmez, Ömer Fatih, Mutlu, Arda Ulaş, Gündoğdu, Yasemin, Seyyar, Mustafa, Şahin, Elif, Çabuk, Devrim, Majidova, Nargiz, Uğurlu, İrem, Demirci, Ayşe, Aydın, Dinçer, Çavdar, Eyyüp, Bayram, Selami, Yıldırım, Nilgün, Karataş, Fatih, Eryılmaz, Melek Karakurt, Çağlayan, Dilek, Menekşe, Serkan, Kut, Engin, Arak, Hacı, Keser, Murat, Sunar, Veli, Perkin, Perihan, Şakalar, Teoman, Oyan, Başak, Sönmez, Özlem, Özer, Leyla, Yıldız, İbrahim

“…Triple negative breast cancer (TNBC) is characterized by high rates of recurrence, especially in patients with residual disease after neoadjuvant chemotherapy…”
Get more information

Real-life comparison of afatinib and erlotinib in non-small cell lung cancer with rare EGFR exon 18 and exon 20 mutations: a Turkish Oncology Group (TOG) study by Gursoy, Pınar, Tatli, Ali Murat, Erdem, Dilek, Goker, Erdem, Celik, Emir, Demirci, Nebi Serkan, Sakin, Abdullah, Atci, Muhammed Mustafa, Bayram, Ertuğrul, Telli, Tuğba Akın, Bilgin, Burak, Bilici, Ahmet, Akangunduz, Baran, Balli, Sevinç, Demirkazik, Ahmet, Selçukbiricik, Fatih, Menekse, Serkan, Cavdar, Eyyüp, Ozturk, Akın, Bekmez, Esma Türkmen, Turhal, Serdal, Kilickap, Sadettin, Yildirim, Hasan Çağrı, Oyan, Başak, Aksoy, Asude, Turkoz, Fatma Paksoy, Kut, Engin, Katgi, Nuran, Sakalar, Teoman, Akyol, Murat, Ellez, Halil İbrahim, Topcu, Atakan, Erdoğan, Atike Pınar, Pilanci, Kezban Nur, Hedem, Engin, Arak, Hacı, Akdeniz, Nadiye, Alan, Özkan, Yapar, Burcu, Nart, Deniz, Yumuk, Perran Fulden

“…Objectives To compare the survival of first- and second-generation tyrosine kinase inhibitors (TKIs) in patients with rare EGFR exon 18 and exon 20…”
Get full text

Atezolizumab combined with chemotherapy in the first-line treatment of extensive-stage small cell lung cancer: a real-life data of the Turkish Oncology Group by Gürbüz, Mustafa, Kutlu, Yasin, Akkuş, Erman, Köksoy, Elif Berna, Köse, Naziyet, Öven, Bala Başak, Uluç, Başak Oyan, Demiray, Atike Gökçen, Erdem, Dilek, Demir, Bilgin, Turhal, Nazım Serdar, Üskent, Necdet, Akbaş, Sinem, Selçukbiricik, Fatih, İnal, Ali, Bilici, Ahmet, Ölmez, Ömer Fatih, Çabuk, Devrim, Ünal, Çağlar, Hızal, Mutlu, Şendur, Mehmet Ali Nahit, Korkmaz, Mustafa, Karadurmuş, Nuri, Ertürk, İsmail, Göksu, Sema Sezgin, Tatlı, Ali Murat, Güven, Deniz Can, Kılıçkap, Saadettin, Paksoy, Nail, Aydıner, Adnan, Çınkır, Havva Yeşil, Özkul, Özlem, Öztürk, Akın, Ballı, Sevinç, Kemal, Yasemin, Erdoğan, Atike Pınar, Er, Özlem, Yumuk, Perran Fulden, Demirkazık, Ahmet

“…Purpose Atezolizumab has been shown to be effective and safe in randomized trial in the first-line treatment of extensive-stage small cell lung cancer (SCLC)…”
Get full text

Correction: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy by Karacin, Cengiz, Oksuzoglu, Berna, Demirci, Ayşe, Keskinkılıç, Merve, Baytemür, Naziyet Köse, Yılmaz, Funda, Selvi, Oğuzhan, Erdem, Dilek, Avşar, Esin, Paksoy, Nail, Demir, Necla, Göksu, Sema Sezgin, Türker, Sema, Bayram, Ertuğrul, Çelebi, Abdüssamet, Yılmaz, Hatice, Kuzu, Ömer Faruk, Kahraman, Seda, Gökmen, İvo, Sakin, Abdullah, Alkan, Ali, Nayır, Erdinç, Uğraklı, Muzafer, Acar, Ömer, Ertürk, İsmail, Demir, Hacer, Aslan, Ferit, Sönmez, Özlem, Korkmaz, Taner, Celayir, Özde Melisa, Karadağ, İbrahim, Kayıkçıoğlu, Erkan, Şakalar, Teoman, Öktem, İlker Nihat, Eren, Tülay, Erul, Enes, Mocan, Eda Eylemer, Kalkan, Ziya, Yıldırım, Nilgün, Ergün, Yakup, Akagündüz, Baran, Karakaya, Serdar, Kut, Engin, Teker, Fatih, Demirel, Burçin Çakan, Karaboyun, Kubilay, Almuradova, Elvina, Ünal, Olçun Ümit, Oyman, Abdilkerim, Işık, Deniz, Okutur, Kerem, Öztosun, Buğra, Gülbağcı, Burcu Belen, Kalender, Mehmet Emin, Şahin, Elif, Seyyar, Mustafa, Özdemir, Özlem, Selçukbiricik, Fatih, Kanıtez, Metin, Dede, İsa, Gümüş, Mahmut, Gökmen, Erhan, Yaren, Arzu, Menekşe, Serkan, Ebinç, Senar, Aksoy, Sercan, İmamoğlu, Gökşen İnanç, Altınbaş, Mustafa, Çetin, Bülent, Uluç, Başak Oyan, Er, Özlem, Karadurmuş, Nuri, Erdoğan, Atike Pınar, Artaç, Mehmet, Tanrıverdi, Özgür, Çiçin, İrfan, Şendur, Mehmet Ali Nahit, Oktay, Esin, Bayoğlu, İbrahim Vedat, Paydaş, Semra, Aydıner, Adnan, Salim, Derya Kıvrak, Geredeli, Çağlayan, Yavuzşen, Tuğba, Doğan, Mutlu, Hacıbekiroğlu, İlhan

Get full text

Optimizing the Personalized Care for the Management of Rectal Cancer: A Consensus Statement by Aytac, Erman, Ozer, Leyla, Baca, Bilgi, Balik, Emre, Kapran, Yersu, Taskin, Orhun Cig, Uluc, Basak Oyan, Abacioglu, Mehmet Ufuk, Gonenc, Murat, Bolukbasi, Yasemin, Cil, Barbaros E, Baran, Bulent, Aygun, Cem, Yildiz, Mehmet Erdem, Unal, Kemal, Erkol, Burcak, Yalti, Tunc, Ozbek, Ugur, Attila, Tan, Tozun, Nurdan, Gurses, Bengi, Erdamar, Sibel, Er, Ozlem, Bese, Nuran, Bilge, Orhan, Ceyhan, Guralp Onur, Mandel, Nil Molinas, Selek, Ugur, Yakicier, Cengiz, Karabey, Hulya Kayserili, Saruc, Murat, Ozben, Volkan, Esen, Eren, Ozoran, Emre, Vardareli, Erkan, Guner, Levent, Hamzaoglu, Ismail, Bugra, Dursun, Karahasanoglu, Tayfun, Group, The Istanbul

“…Colorectal cancer is the third most common cancer in Turkey. The current guidelines do not provide sufficient information to cover all aspects of the…”
Get full text

Efficacy of Palbociclib and Endocrine Treatment in Heavily Pretreated Hormone Receptor-positive/HER2-negative Advanced Breast Cancer: Retrospective Multicenter Trial by Demir, Atakan, Mandel, Nil Molinas, Paydas, Semra, Demir, Gökhan, Er, Özlem, Turhal, Nazım Serdal, Bavbek, Sevil, Eralp, Yeşim, Saip, Pınar Mualla, Güler, Emine Nilüfer, Aydıner, Adnan, Oyan Uluç, Başak, Kılıçkap, Sadettin, Üskent, Necdet, Karadurmuş, Nuri, Kaplan, Mehmet Ali, Yanmaz, Mustafa Teoman, Demir, Hacer, Alan, Özkan, Korkmaz, Taner, Olgun, Polat, Sönmez Uysal, Özlem, Altundağ, Kadri, Gündüz, Şeyda, Günaldı, Meral, Sarı, Murat, Beypınar, İsmail, Başaran, Gül

“…The synthesis of CDK4/6 inhibitors with endocrine treatment in two series of treatment has been widely accepted as the standard for patients with estrogen…”
Get full text

Three Cases of Breast Metastases from Lung Cancer and Systematic Review of the Literature by Güldoğan, Nilgün, İçten, Gül Esen, Tokat, Fatma, Tutar, Burçin, Kara, Halil, Korkmaz, Taner, Oyan Uluç, Başak, Demir, Gökhan

“…Despite the high prevalence of lung cancer among other primary tumors, metastasis of this particular malignancy in the breast is very rare. We report three new…”
Get full text

Turkish national consensus on breast cancer management during temporary state of emergency due to COVID-19 outbreak by Sezer, Atakan, Cicin, İrfan, Karadeniz Çakmak, Güldeniz, Özkan Gürdal, Sibel, Başaran, Gül, Oyan, Başak, Eralp, Yeşim, Güllüoğlu, Bahadır M.

Get full text

Identifying Knowledge and Practices regarding Cancer Patient Malnutrition: A Survey Study among Oncologists by Sonmez, Ozlem, Tezcanli, Evrim, Bas, Dilsat, Kazanci, Hande Busra, Altinok, Ayse, Demir, Atakan, Uluc, Basak Oyan

“…Malnutrition is one of the most common complications of cancer and its treatments with a prevalence of up to 80% among cancer patients. Thus, standardized and…”
Get full text

Bone-targeted Agents Used in Breast Cancer Patients with Bone Metastases by oyan, başak

Get full text

Side Effects and Management: Osteonecrosis of Jaw and Acute Phase Reaction by oyan, başak

Get full text

Validation of bioelectrical impedance analysis in the evaluation of body composition in patients with breast cancer by Baş, Dilşat, Arıbal, Mustafa Erkin, Vardareli, Erkan, Sönmez, Özlem, Oyan, Başak, Özden, Burcu Çelet, Sonkaya, Alper

“…Background The evaluation of body composition is an essential parameter for preventing obesity and sarcopenic obesity, which are prognostic factors in breast…”
Get full text

HER2-targeted therapy in breast cancer: A systematic review of neoadjuvant trials by Dent, Susan, Oyan, Basak, Honig, Arnd, Mano, Max, Howell, Sacha

“…Abstract Targeting human epidermal growth factor receptor 2 (HER2) during or in sequence with chemotherapy improves overall survival in metastatic and early…”
Get full text

Alprazolam significantly improves the efficacy of granisetron in the prophylaxis of emesis secondary to moderately emetogenic chemotherapy in patients with breast cancer by Abali, Huseyin, Oyan, Başak, Guler, Nilufer

“…Alprazolam, a newer benzodiazepine, may be useful in the control of nausea and vomiting in breast cancer patients. Nineteen operable breast cancer patients…”
Get more information

Coronaphobia: A barrier to ongoing cancer treatment? by Sönmez, Özlem, Tezcanli, Evrim, Taşçı, Elif Şenocak, Kazancı, Hande Büşra, Altınok, Ayşe, Toklucu, Elvan, Taşçı, Yusuf, Aydoğdu, Çise, Aydın, Ayşegül Bakır, Yüce, Sabiha, Oyan, Başak

“…Introduction Increased stress levels caused by the pandemic might cause delays in cancer treatment. We conducted a survey among cancer patients undergoing…”
Get full text

The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study by Özdemir, Özlem, Zengel, Baha, Yildiz, Yaşar, Uluç, Basak Oyan, Cabuk, Devrim, Ozden, Ercan, Salim, Derya Kivrak, Paydas, Semra, Demir, Atakan, Diker, Omer, Pilanci, Kezban Nur, Sönmez, Özlem Uysal, Vatansever, Sezai, Dogan, Izzet, Gulmez, Ahmet, Cakar, Burcu, Gursoy, Pinar, Yildirim, Mahmut Emre, Ayhan, Murat, Karadurmus, Nuri, Aykan, Musa Baris, Cevik, Gökcen Tugba, Sakalar, Teoman, Hacibekiroglu, Ilhan, Gülbagci, Burcu Belen, Dincer, Murat, Garbioglu, Duygu Bayir, Kemal, Yasemin, Nayir, Erdinc, Taskaynatan, Halil, Yilmaz, Mesut, Avci, Okan, Sari, Murat, Coban, Ezgi, Atci, Muhammed Mustafa, Esen, Selin Aktürk, Telli, Tugba Akin, Karatas, Fatih, Inal, Ali, Demir, Hacer, Kalkan, Nurhan Onal, Yilmaz, Cengiz, Tasli, Funda, Alacacioglu, Ahmet

“…In our study, we aimed to evaluate the pathological response rates and side effect profile of adding pertuzumab to the treatment of HER2+ locally advanced,…”
Get full text